ADHD 2025 | Final Programme

SCIENTIFIC PROGRAMME Thursday, 8 May 2025

GA-01 General Assembly 14:00 – 14:45

HT-03 Hot Topic Session 15:00 – 16:30

Club A

North Hall

General Assembly of WFADHD Access for members of the WFADHD and nominated representatives of affiliated associations only.

ADHD and global crises Chairs: Thomas Müller, Switzerland Jeffrey Newcorn, USA 001

Prenatal exposure to a natural disaster and early development of psychiatric disorders during the preschool years: Stress in preg- nancy study Jeffrey Newcorn, USA The effect of COVID-19 Pandemic on ADHD Mark Bellgrove, Australia

HT-01 Hot Topic Session 15:00 – 16:30

Congress Hall Should I need to worry about cardiovascular risks out- comes in my patients with ADHD treated with psy- chostimulants? Chairs: Samuele Cortese, United Kingdom Jonna Kuntsi, United Kingdom 001 ADHD medications and long-term risk of cardiovascular diseases Zheng Chang, Sweden 002 Long-term cardiovascular safety of methyl- phenidate in children and adolescents with ADHD: 2-year outcomes of the ADHD Drugs Use Chronic Effects (ADDUCE) study Ian Chi Kei Wong, Hong Kong

002

003

ADHD and climate change Thomas Müller, Switzerland

HT-04 Hot Topic Session 15:00 – 16:30

South Hall 2A

Navigating ADHD in the perinatal period Chairs: Kathrine Bang Madsen, Denmark Lotta Borg Skoglund, Sweden 001

It’s all in your head: Hormonal changes across the female reproductive life Helena Kopp Kallner, Sweden M aternal mental health in the perinatal period: Challenges and strategies for women with ADHD Lotta Borg Skoglund, Sweden Short and long-term outcomes for infants exposed to ADHD medications in utero Kathrine Bang Madsen, Denmark ADHD medication use during pregnancy: Balancing benefits and risks Jacqueline Mallory Cohen, Norway

003

ADHD Remote Technology study of cardio- metabolic risk factors and medication adher- ence (ART-CARMA): A multi-centre prospective cohort study Jonna Kuntsi, United Kingdom Comparative cardiovascular side effects of medications for ADHD in children, adolescents and adults: Systematic review and network meta-analysis Samuele Cortese, United Kingdom

002

004

003

004

HT-02 Hot Topic Session 15:00 – 16:30

Panorama Hall

HT-05 Hot Topic Session 15:00 – 16:30

The lancet psychiatry series on ADHD Chairs: David Coghill, Australia Luis Augusto Rohde, Brazil 001

South Hall 2B Joint Symposium of the Affiliated Societies of the World Federation of ADHD Chairs: Sandra Kooij, The Netherlands Arnstein Mykletun, Norway 001 (Not) sleeping and suffering: the interplay bet- ween AD(H)D, sleep disorders and psychiatric comorbidity Dora Wynchank, The Netherlands

C urrent evidence and gaps on global ADHD and treatment epidemiology Adrienne Chan, United Kingdom What are the real-world long-term impacts of ADHD and its treatment: Clinical, societal, economic and political implications Patrick Ip, Hong Kong Barriers and facilitators for improving equity of access to ADHD care Luis Augusto Rohde, Brazil

002

003

002

The effect of light therapy on ADHD symptoms in adults Sandra Kooij, The Netherlands

004

Psychoeducation and advocacy David Coghill, Australia

15

Made with FlippingBook Digital Publishing Software